Aratana files for second FDA approval

A day after receiving its first Food and Drug Administration approval, Aratana Therapeutics Inc. (Nasdaq: PETX) announced Tuesday that it has applied for a second FDA approval. The Leawood-based pet therapeutics company submitted an administrative New Animal Drug Application with the FDA's Center for Veterinary Medicine for the drug Entyce. Entyce is a flavored, oral liquid prescription that helps stimulate appetite in dogs. The chemical entity is a "first-of-its kind therapeutic" that works by…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news